Guyatt, Anna L.
Brennan, Rebecca R.
Burrows, Kimberley
Guthrie, Philip A. I.
Ascione, Raimondo
Ring, Susan M.
Gaunt, Tom R.
Pyle, Angela
Cordell, Heather J.
Lawlor, Debbie A.
Chinnery, Patrick F.
Hudson, Gavin
Rodriguez, Santiago
Funding for this research was provided by:
Wellcome Trust (102215/2/13/2, WT088806, 096919/Z/11/Z, 096919/Z/11/Z, WT092830M, 101876/Z/13/Z)
Medical Research Council (MR/K002767/1, MC_UU_12013/5, MC_UU_12013/8, G1001357, MC_UP_1501/2, G0601943)
Wellcome Trust (102433/Z/13/Z)
PDUK (F-1202)
British Heart Foundation (SP/07/008/24066)
Article History
Received: 5 October 2018
Accepted: 27 December 2018
First Online: 31 January 2019
Ethics approval and consent to participate
: The ALSPAC study has ethical approval. Specific ethical approval for this particular project was not required, but permission to undertake the research was granted by the ALSPAC executive committee.
: Not applicable.
: TRG reports funding from Sanofi, Biogen, and GlaxoSmithKline for projects unrelated to the work presented in this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.